Get the Stockscreener App
0.2404
13.57%
-0.1796
After Hours:
.24
-0.0004
-0.17%
Avenue Therapeutics Inc Stock (ATXI) Forecast
The Avenue Therapeutics Inc (ATXI) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $108.54, representing a +45,050% increase from the current price of $0.2404. The highest analyst price target is $125.14, and the lowest is $91.94.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ATXI Price Target
Average 68.97
(+28,589% Upside)
Is Avenue Therapeutics Inc (ATXI) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 0.00 | Neutral |
| STOCH(9,6) | 0.00 | Buy |
| STOCHRSI(14) | 0.00 | Neutral |
| MACD(12,26) | 0.00 | Neutral |
| ADX(14) | 0.00 | Neutral |
| William %R | -100.00 | Buy |
| CCI(14) | 0.00 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.026
Buy
|
0.00
Buy
|
| MA20 |
0.013
Buy
|
0.00
Buy
|
| MA50 |
0.00519
Buy
|
0.00
Buy
|
| MA100 |
0.0026
Buy
|
0.00
Buy
|
| MA200 |
0.0013
Buy
|
0.00
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, ATXI could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 0 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on ATXI, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 0 indicates that ATXI is oversold. This indicates that ATXI price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 0 indicates that ATXI is oversold. This indicates that ATXI price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 0 indicates that ATXI is oversold. This suggests that ATXI price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 0 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 0 indicates that ATXI is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term ATXI price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Avenue Therapeutics Inc financial reports and earnings history, Avenue Therapeutics Inc (ATXI) stock could reach $56.52 by 2030, $52.01 by 2040 and $151.65 by 2050. See the projected annual prices until 2050 of the Avenue Therapeutics Inc stock below:
- Avenue Therapeutics Inc (ATXI) is expected to reach an average price of $20.19 in 2035, with a high prediction of $21.63 and a low estimate of $20.19. This indicates an $8,297% rise from the last recorded price of $0.2404.
- Avenue Therapeutics Inc (ATXI) stock is projected to chart a bullish course in 2040, with an average price target of $50.57, representing an $20,935% surge from its current level. The forecast ranges from a conservative $50.65 to a sky-high $52.01.
- Our analysts predict Avenue Therapeutics Inc (ATXI) to jump 38,649% by 2045, soaring from $93.15 to an average price of $93.15, potentially reaching $89.43. While $93.15 is the low estimate, the potential upside is significant.
- Avenue Therapeutics Inc (ATXI) stock is expected to climb by 2050, reaching an average of $143.46, a $59,575% jump from its current level. However, a wide range of estimates exists, with high and low targets of $151.65 and $144.67, respectively, highlighting the market's uncertainty.
Avenue Therapeutics Inc Stock (ATXI) Year by Year Forecast
Avenue Therapeutics Inc Stock (ATXI) Price Forecast for 2025
Avenue Therapeutics Inc Stock (ATXI) is expected to reach an average price of $69.91 in 2025, with a high prediction of $136.49 and a low estimate of $3.3242. This indicates an +28,979% rise from the last recorded price of $0.2404.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $111.36 | $91.94 | $125.14 | +46,223% |
| August, 2025 | $95.53 | $89.46 | $119.51 | +39,638% |
| September, 2025 | $104.15 | $87.53 | $113.55 | +43,225% |
| October, 2025 | $122.58 | $104.06 | $134.49 | +50,890% |
| November, 2025 | $114.25 | $110.05 | $136.49 | +47,426% |
| December, 2025 | $0.0704 | $3.3242 | $122.11 | -70.74% |
Avenue Therapeutics Inc Stock (ATXI) Price Forecast for 2026
The predicted value for Avenue Therapeutics Inc (ATXI) in 2026 is set at an average of $36.46. Estimates vary from a peak of $71.47 to a trough of $1.446, indicating an +15,065% surge from the present price of $0.2404.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $4.8015 | $1.446 | $5.5515 | +1,897% |
| February, 2026 | $48.82 | $3.2624 | $63.82 | +20,209% |
| March, 2026 | $48.75 | $38.73 | $59.68 | +20,177% |
| April, 2026 | $36.72 | $33.06 | $71.47 | +15,176% |
| May, 2026 | $53.59 | $25.60 | $65.78 | +22,194% |
| June, 2026 | $60.87 | $37.21 | $65.97 | +25,219% |
| July, 2026 | $21.84 | $16.16 | $71.27 | +8,986% |
| August, 2026 | $22.97 | $20.37 | $37.18 | +9,453% |
| September, 2026 | $3.4574 | $1.7128 | $6.5208 | +1,338% |
| October, 2026 | $11.94 | $10.60 | $10.29 | +4,865% |
| November, 2026 | $10.36 | $12.63 | $12.08 | +4,211% |
| December, 2026 | $14.14 | $11.36 | $11.94 | +5,780% |
Avenue Therapeutics Inc Stock (ATXI) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Avenue Therapeutics Inc (ATXI) is $19.81, with a high forecast of $27.61 and a low forecast of $12.00. This indicates an +8,139% increase from the last price of $0.2404.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $16.76 | $13.78 | $15.62 | +6,874% |
| February, 2027 | $16.54 | $12.00 | $13.99 | +6,781% |
| March, 2027 | $19.86 | $16.77 | $17.92 | +8,163% |
| April, 2027 | $19.79 | $20.00 | $18.97 | +8,134% |
| May, 2027 | $20.98 | $21.66 | $21.28 | +8,626% |
| June, 2027 | $18.51 | $23.04 | $27.61 | +7,600% |
| July, 2027 | $23.10 | $21.38 | $20.67 | +9,509% |
| August, 2027 | $22.32 | $22.53 | $22.77 | +9,183% |
| September, 2027 | $24.57 | $24.05 | $23.57 | +10,121% |
| October, 2027 | $23.90 | $23.96 | $23.47 | +9,842% |
| November, 2027 | $22.61 | $23.21 | $23.43 | +9,305% |
| December, 2027 | $21.47 | $21.89 | $22.12 | +8,830% |
Avenue Therapeutics Inc Stock (ATXI) Price Forecast for 2028
In 2028, Avenue Therapeutics Inc (ATXI) is projected to reach an average price of $17.68, with a high projection of $21.36 and a low estimate of $14.01. This indicates an +7,256% rise from the last price of $0.2404.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $21.56 | $21.59 | $21.36 | +8,869% |
| February, 2028 | $14.08 | $20.68 | $19.38 | +5,756% |
| March, 2028 | $20.74 | $20.77 | $20.63 | +8,528% |
| April, 2028 | $20.90 | $20.95 | $20.76 | +8,594% |
| May, 2028 | $20.06 | $20.22 | $20.65 | +8,245% |
| June, 2028 | $18.96 | $19.21 | $19.75 | +7,787% |
| July, 2028 | $18.43 | $18.48 | $18.67 | +7,566% |
| August, 2028 | $17.50 | $17.59 | $18.14 | +7,180% |
| September, 2028 | $16.55 | $16.68 | $17.20 | +6,784% |
| October, 2028 | $15.95 | $16.07 | $16.28 | +6,534% |
| November, 2028 | $14.82 | $14.88 | $15.68 | +6,065% |
| December, 2028 | $13.95 | $14.01 | $14.53 | +5,702% |
Avenue Therapeutics Inc Stock (ATXI) Price Forecast for 2029
The 2029 price forecast for Avenue Therapeutics Inc Stock (ATXI) is $30.08 on average, with a high prediction of $60.08 and a low estimate of $0.0869. This represents an +12,414% increase from the previous price of $0.2404.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $13.04 | $13.06 | $13.74 | +5,325% |
| February, 2029 | $12.44 | $12.44 | $12.79 | +5,074% |
| March, 2029 | $11.62 | $11.73 | $12.18 | +4,733% |
| April, 2029 | $11.03 | $11.07 | $11.39 | +4,486% |
| May, 2029 | $10.37 | $10.40 | $10.81 | +4,215% |
| June, 2029 | $9.5844 | $9.5964 | $10.17 | +3,887% |
| July, 2029 | $8.7936 | $8.8136 | $9.3673 | +3,558% |
| August, 2029 | $7.7793 | $7.7863 | $8.3962 | +3,136% |
| September, 2029 | $6.971 | $6.9735 | $7.5688 | +2,800% |
| October, 2029 | $5.9269 | $5.9306 | $6.7401 | +2,365% |
| November, 2029 | $5.1263 | $5.1411 | $5.7127 | +2,032% |
| December, 2029 | $60.08 | $0.0869 | $60.08 | +24,892% |
Avenue Therapeutics Inc Stock (ATXI) Price Forecast for 2030
Avenue Therapeutics Inc Stock (ATXI) is expected to reach an average price of $28.37 in 2030, with a high forecast of $56.52 and a low forecast of $0.2224. This signifies an +11,701% surge from the last price of $0.2404.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $37.63 | $40.48 | $56.52 | +15,551% |
| February, 2030 | $32.38 | $35.98 | $31.89 | +13,370% |
| March, 2030 | $34.64 | $37.26 | $34.04 | +14,308% |
| April, 2030 | $28.19 | $32.09 | $34.68 | +11,628% |
| May, 2030 | $31.24 | $29.47 | $31.24 | +12,895% |
| June, 2030 | $35.45 | $35.93 | $34.21 | +14,645% |
| July, 2030 | $26.94 | $31.92 | $32.34 | +11,107% |
| August, 2030 | $0.0977 | $9.9737 | $25.62 | -59.35% |
| September, 2030 | $18.68 | $1.6368 | $32.52 | +7,670% |
| October, 2030 | $45.90 | $12.76 | $56.40 | +18,993% |
| November, 2030 | $4.5057 | $0.2224 | $50.06 | +1,774% |
| December, 2030 | $25.04 | $9.0915 | $29.84 | +10,315% |
1.11%
1.70%
Cap:
|
Volume (24h):